Ocugen Inc. Common Stock (NASDAQ: OCGN)
34 Days left to seek lead plaintiff status.
Plaintiff brings this class action to remedy: (i) the Company’s violation of Ocugen’s Sixth Amended and Restated Certificate of Incorporation, as amended through April 15, 2021 (the “Charter”);1 (ii) the resultant invalid adoption of an
amendment to the Charter that purported to increase the number of authorized shares of common stock (the “Charter Amendment”), and (iii) Ocugen’s invalid attempt at retroactively correcting the defect by filing the Certificate of Correction to the Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock (the “Correction Certificate”).